"Exciting results from @josephmurrayMD et al demonstrating immune tolerance to gliadin with KAN-101. Big takeaways: &#128165;Anergic phenotype in gliadin-specific T-cells with KAN-101 &#128165;Dose-dependent down-regulation of key cytokines #DDW23 #celiacdisease"

KAN-101 - Anokion

May 9, 2023